Stock IPCI.H INTELLIPHARMACEUTICS INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Intellipharmaceutics International Inc.

Equities

IPCI.H

CA4581733090

Delayed Toronto S.E.
Other stock markets
 12:00:00 2024-03-21 pm EDT 		5-day change 1st Jan Change
0.08 CAD -.--% Intraday chart for Intellipharmaceutics International Inc. -11.11% +6.67%
Jan. 03 IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing MT
2023 Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023
IntelliPharmaCeutics International Fiscal Q2 Loss Narrows on Higher Revenue
Intellipharmaceutics International Narrows Fiscal Q1 Loss, Revenue Rises
Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022
Intellipharmaceutics International Fiscal Q3 Loss Widens
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022
IntelliPharmaCeutics International Fiscal Q1 Loss Narrows
Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt
Intellipharmaceutics International Inc. Reports Earnings Results for the Full Year Ended November 30, 2021
Intellipharmaceutics International Inc. Announces Kenneth Keirstead, A Member of Board of Directors, Passed Away
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2021
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2021
IntelliPharmaCeutics International : Up 12% as it Raises C$3.85 Million in Private Share Placement
Intellipharmaceutics International : Details Q1 2021 Results
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2021
Intellipharmaceutics International Inc. Reports Earnings Results for the Full Year Ended November 30, 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IPCI.H Stock
  4. News Intellipharmaceutics International Inc.
  5. Other languages